<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778722</url>
  </required_header>
  <id_info>
    <org_study_id>LP2021/INF1.1</org_study_id>
    <nct_id>NCT04778722</nct_id>
  </id_info>
  <brief_title>Microbiome Vaginae After Use of Oral Probiotics in Pregnancy.</brief_title>
  <official_title>Development of Microbiome Vaginae After Use of Oral Probiotics in First the Trimester of Pregnancy. A Prospective Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Associate Prof. Ljubomir Petricevic MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Change of Vaginal microbiome in first trimester pregnant women after oral intake of Probiotic&#xD;
      preparation with 4 lactobacilli strains&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Although the research of the vaginal microbiome is taking faster pace in recent years than it&#xD;
      was the case before, there is still lack of information, about its composition, how and when&#xD;
      it changes and how that can affect processes in the female body.&#xD;
&#xD;
      During pregnancy, the microbiome physiologically gets increasingly stable. Diversity of&#xD;
      bacteria decreases, which is the sign of a healthy microbiome, and Lactobacillus species&#xD;
      increase their already pre-existing dominance. Acidic metabolites of those bacteria maintain&#xD;
      the low pH and low diversity in vagina.&#xD;
&#xD;
      If the dominance of lactobacilli is not as large as it should be, the risk of preterm birth&#xD;
      increases significantly. Low relative abundance of Lactobacillus species, especially&#xD;
      Lactobacillus crispatus (marker of the healthy microbiome) and lactobacillus metabolites as&#xD;
      well as high vaginal microbial diversity are most significantly connected with preterm birth.&#xD;
&#xD;
      Despite such a high relevance of vaginal microbiome for a healthy pregnancy, and for women's&#xD;
      health in general, there's an insufficient proof that the intake of oral probiotics can&#xD;
      change it. The aim of our study is to see if the intake of patented dietary supplement,&#xD;
      containing four Lactobacillus strains can change the relative abundance of different bacteria&#xD;
      in the vaginal microbiome. This could lay ground for further research in this area and even&#xD;
      create new therapeutic approaches in the future.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 15, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Receiving Oral Probiotics</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CST</measure>
    <time_frame>14 Days</time_frame>
    <description>change of vaginal microbiome after probiotic intake</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lactobacilli Change</measure>
    <time_frame>14 Days</time_frame>
    <description>change of relative abundances of each Lactobacillus species contained in the probiotic</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Pregnancy; Infection Genitourinary System</condition>
  <arm_group>
    <arm_group_label>Probiotic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>pilot study with one interventional group</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral probiotics</intervention_name>
    <description>containing four Lactobacillus strains (Lactobacillus crispatus -Lbv88, Lactobacillus rhamnosus -Lbv96, Lactobacillus jensenii -Lbv116, and Lactobacillus gasseri -Lbv150)</description>
    <arm_group_label>Probiotic group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnant women aged between 18 and 45&#xD;
&#xD;
          -  infection screening during a prenatal consultation between 10+0 (10 weeks plus 0 days)&#xD;
             and 16+0 (16 weeks plus 0 days) gestational weeks&#xD;
&#xD;
          -  Singleton pregnancy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Vaginal infections such as Bacterial vaginosis, candida vaginitis, trichomoniasis,&#xD;
             mycoplasma, gonococcal infection&#xD;
&#xD;
          -  Antibiotic therapy in the last 4 weeks&#xD;
&#xD;
          -  Probiotic therapy in the last 4 weeks&#xD;
&#xD;
          -  Operation on gastrointestinal tract&#xD;
&#xD;
          -  Diarrhoea, obstipation&#xD;
&#xD;
          -  Vaginal bleeding&#xD;
&#xD;
          -  Patients with hormone disorders of any kind&#xD;
&#xD;
          -  Other chronic diseases (Diabetes, Autoimmune diseases etc.)&#xD;
&#xD;
          -  HIV&#xD;
&#xD;
          -  Gestational diabetes&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>First trimester Pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ljubomir Petricevic, Prof Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 23, 2021</study_first_submitted>
  <study_first_submitted_qc>February 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Associate Prof. Ljubomir Petricevic MD</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>probiotics</keyword>
  <keyword>pregnant women</keyword>
  <keyword>microbiome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy Complications, Infectious</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

